Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Verrica Pharmaceuticals (VRCA) has provided an announcement.
Joe Bonaccorso has announced his resignation as the Chief Commercial Officer of Verrica Pharmaceuticals Inc., effective August 30, 2024. As part of his separation, he is set to receive a year’s base salary and potentially 12 months of paid health coverage. Furthermore, he will enter a consulting role with the company until August 2025, during which he will not receive cash compensation but will continue to vest in stock options and awards.
For detailed information about VRCA stock, go to TipRanks’ Stock Analysis page.